JP2024137967A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024137967A5 JP2024137967A5 JP2024112452A JP2024112452A JP2024137967A5 JP 2024137967 A5 JP2024137967 A5 JP 2024137967A5 JP 2024112452 A JP2024112452 A JP 2024112452A JP 2024112452 A JP2024112452 A JP 2024112452A JP 2024137967 A5 JP2024137967 A5 JP 2024137967A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- position corresponding
- amino acid
- acid sequence
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (16)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862785391P | 2018-12-27 | 2018-12-27 | |
| US62/785,391 | 2018-12-27 | ||
| US201962790256P | 2019-01-09 | 2019-01-09 | |
| US201962790266P | 2019-01-09 | 2019-01-09 | |
| US201962790261P | 2019-01-09 | 2019-01-09 | |
| US201962790262P | 2019-01-09 | 2019-01-09 | |
| US201962790258P | 2019-01-09 | 2019-01-09 | |
| US62/790,258 | 2019-01-09 | ||
| US62/790,261 | 2019-01-09 | ||
| US62/790,256 | 2019-01-09 | ||
| US62/790,266 | 2019-01-09 | ||
| US62/790,262 | 2019-01-09 | ||
| US201962932169P | 2019-11-07 | 2019-11-07 | |
| US62/932,169 | 2019-11-07 | ||
| PCT/US2019/068079 WO2020139783A2 (en) | 2018-12-27 | 2019-12-20 | Polypeptides useful for gene editing and methods of use |
| JP2021538143A JP7572360B2 (ja) | 2018-12-27 | 2019-12-20 | 遺伝子編集に有用なポリペプチドと利用方法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021538143A Division JP7572360B2 (ja) | 2018-12-27 | 2019-12-20 | 遺伝子編集に有用なポリペプチドと利用方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024137967A JP2024137967A (ja) | 2024-10-07 |
| JP2024137967A5 true JP2024137967A5 (enExample) | 2025-04-17 |
Family
ID=69182752
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021538143A Active JP7572360B2 (ja) | 2018-12-27 | 2019-12-20 | 遺伝子編集に有用なポリペプチドと利用方法 |
| JP2024008844A Pending JP2024050676A (ja) | 2018-12-27 | 2024-01-24 | 遺伝子編集に有用なポリペプチドと利用方法 |
| JP2024112452A Pending JP2024137967A (ja) | 2018-12-27 | 2024-07-12 | 遺伝子編集に有用なポリペプチドと利用方法 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021538143A Active JP7572360B2 (ja) | 2018-12-27 | 2019-12-20 | 遺伝子編集に有用なポリペプチドと利用方法 |
| JP2024008844A Pending JP2024050676A (ja) | 2018-12-27 | 2024-01-24 | 遺伝子編集に有用なポリペプチドと利用方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (4) | US20220145296A1 (enExample) |
| EP (2) | EP4339286A3 (enExample) |
| JP (3) | JP7572360B2 (enExample) |
| KR (1) | KR20210149686A (enExample) |
| CN (1) | CN113631704A (enExample) |
| AU (2) | AU2019416108B2 (enExample) |
| BR (1) | BR112021012665A2 (enExample) |
| ES (1) | ES2970169T3 (enExample) |
| IL (2) | IL312708A (enExample) |
| MX (1) | MX2021007835A (enExample) |
| NZ (1) | NZ778392A (enExample) |
| SG (1) | SG11202106977PA (enExample) |
| TW (1) | TW202039847A (enExample) |
| WO (1) | WO2020139783A2 (enExample) |
| ZA (1) | ZA202105281B (enExample) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL279222B2 (en) * | 2018-06-05 | 2025-10-01 | Lifeedit Inc | RNA-guided nucleases and active variant fragments thereof and methods of use |
| TW202208626A (zh) * | 2020-04-24 | 2022-03-01 | 美商生命編輯公司 | Rna引導核酸酶及其活性片段與變體，以及使用方法 |
| CN116194581A (zh) | 2020-07-01 | 2023-05-30 | 艾勒维生技公司 | 使用环状rna进行细胞重编程的组合物和方法 |
| EP4182454A1 (en) | 2020-07-15 | 2023-05-24 | Lifeedit Therapeutics, Inc. | Uracil stabilizing proteins and active fragments and variants thereof and methods of use |
| IL301139A (en) | 2020-09-11 | 2023-05-01 | Lifeedit Therapeutics Inc | Enzymes from secondary DNA and active fragments and their variants and methods of use |
| CA3173950A1 (en) | 2021-03-22 | 2022-09-22 | Tyson D. BOWEN | Dna modifyng enzymes and active fragments and variants thereof and methods of use |
| CA3219767A1 (en) * | 2021-05-14 | 2022-11-17 | Beam Therapeutics Inc. | Compositions and methods for treating transthyretin amyloidosis |
| CA3173953A1 (en) | 2021-06-11 | 2023-12-10 | Tyson D. BOWEN | Rna polymerase iii promoters and methods of use |
| EP4101928A1 (en) * | 2021-06-11 | 2022-12-14 | Bayer AG | Type v rna programmable endonuclease systems |
| BR112023023768A2 (pt) * | 2021-06-11 | 2024-02-27 | Bayer Ag | Sistemas de endonucleases programáveis por rna tipo v |
| EP4396363A1 (en) | 2021-09-02 | 2024-07-10 | Sanofi | Compositions and methods for rna affinity purification |
| EP4412590A1 (en) | 2021-10-05 | 2024-08-14 | Sanofi | Methods for freezing and freeze-drying lipid nanoparticles (lnps) and lnps obtained with the same |
| EP4453191A1 (en) * | 2021-12-23 | 2024-10-30 | Bayer Aktiengesellschaft | Novel small type v rna programmable endonuclease systems |
| CA3248846A1 (en) | 2022-01-17 | 2023-07-20 | Sanofi | Lipid Compounds and Their Uses |
| WO2023141602A2 (en) | 2022-01-21 | 2023-07-27 | Renagade Therapeutics Management Inc. | Engineered retrons and methods of use |
| AU2023208961A1 (en) * | 2022-01-24 | 2024-09-12 | Life Edit Therapeutics, Inc. | Rna-guided nucleases and active fragments and variants thereof and methods of use |
| CN119421716A (zh) | 2022-06-17 | 2025-02-11 | 赛诺菲 | 用于环状rna亲和纯化的组合物和方法 |
| EP4558624A2 (en) | 2022-07-18 | 2025-05-28 | Renagade Therapeutics Management Inc. | Gene editing components, systems, and methods of use |
| CN120112633A (zh) | 2022-08-12 | 2025-06-06 | 生命编辑治疗股份有限公司 | Rna引导的核酸酶及其活性片段和变体以及使用方法 |
| WO2024044723A1 (en) | 2022-08-25 | 2024-02-29 | Renagade Therapeutics Management Inc. | Engineered retrons and methods of use |
| TW202424186A (zh) | 2022-08-25 | 2024-06-16 | 美商生命編輯治療學公司 | Rna引導核酸酶中介基因編輯用之具鎖核酸引導 rna之化學修飾 |
| TW202434726A (zh) | 2022-11-04 | 2024-09-01 | 美商生命編輯治療學公司 | 具內部插入位進化腺嘌呤去胺及rna引導之核酸酶融合蛋白及其使用方法 |
| WO2024127369A1 (en) | 2022-12-16 | 2024-06-20 | LifeEDIT Therapeutics, Inc. | Guide rnas that target foxp3 gene and methods of use |
| CA3277009A1 (en) | 2022-12-16 | 2024-06-20 | Life Edit Therapeutics, Inc. | RNA GUIDELINES TARGETING THE TRAC GENE AND METHODS OF USE |
| WO2024178397A2 (en) | 2023-02-24 | 2024-08-29 | Elevatebio Technologies, Inc. | Modified immune effector cells and methods of use |
| WO2024235991A1 (en) * | 2023-05-15 | 2024-11-21 | UCB Biopharma SRL | Rna-guided nucleases and nucleic acid targeting systems comprising such rna-guided nucleases |
| WO2025003344A1 (en) * | 2023-06-28 | 2025-01-02 | Alia Therapeutics Srl | Type ii cas proteins and applications thereof |
| WO2025022367A2 (en) | 2023-07-27 | 2025-01-30 | Life Edit Therapeutics, Inc. | Rna-guided nucleases and active fragments and variants thereof and methods of use |
| WO2025081042A1 (en) | 2023-10-12 | 2025-04-17 | Renagade Therapeutics Management Inc. | Nickase-retron template-based precision editing system and methods of use |
| WO2025083619A1 (en) | 2023-10-18 | 2025-04-24 | Life Edit Therapeutics, Inc. | Rna-guided nucleases and acive fragments and variants thereof and methods of use |
| WO2025155753A2 (en) | 2024-01-17 | 2025-07-24 | Renagade Therapeutics Management Inc. | Improved gene editing system, guides, and methods |
| WO2025174908A1 (en) | 2024-02-12 | 2025-08-21 | Life Edit Therapeutics, Inc. | Novel rna-guided nucleases and proteins for polymerase editing |
| WO2025231360A1 (en) * | 2024-05-03 | 2025-11-06 | Modernatx, Inc. | Novel cas nucleases and polynucleotides encoding the same |
Family Cites Families (72)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4217344A (en) | 1976-06-23 | 1980-08-12 | L'oreal | Compositions containing aqueous dispersions of lipid spheres |
| US4196265A (en) | 1977-06-15 | 1980-04-01 | The Wistar Institute | Method of producing antibodies |
| US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
| US4186183A (en) | 1978-03-29 | 1980-01-29 | The United States Of America As Represented By The Secretary Of The Army | Liposome carriers in chemotherapy of leishmaniasis |
| US4261975A (en) | 1979-09-19 | 1981-04-14 | Merck & Co., Inc. | Viral liposome particle |
| US4485054A (en) | 1982-10-04 | 1984-11-27 | Lipoderm Pharmaceuticals Limited | Method of encapsulating biologically active materials in multilamellar lipid vesicles (MLV) |
| US4501728A (en) | 1983-01-06 | 1985-02-26 | Technology Unlimited, Inc. | Masking of liposomes from RES recognition |
| US5380831A (en) | 1986-04-04 | 1995-01-10 | Mycogen Plant Science, Inc. | Synthetic insecticidal crystal protein gene |
| US4946787A (en) | 1985-01-07 | 1990-08-07 | Syntex (U.S.A.) Inc. | N-(ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
| US4897355A (en) | 1985-01-07 | 1990-01-30 | Syntex (U.S.A.) Inc. | N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
| US5049386A (en) | 1985-01-07 | 1991-09-17 | Syntex (U.S.A.) Inc. | N-ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)Alk-1-YL-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
| US4797368A (en) | 1985-03-15 | 1989-01-10 | The United States Of America As Represented By The Department Of Health And Human Services | Adeno-associated virus as eukaryotic expression vector |
| US5569597A (en) | 1985-05-13 | 1996-10-29 | Ciba Geigy Corp. | Methods of inserting viral DNA into plant material |
| US4774085A (en) | 1985-07-09 | 1988-09-27 | 501 Board of Regents, Univ. of Texas | Pharmaceutical administration systems containing a mixture of immunomodulators |
| US4853331A (en) | 1985-08-16 | 1989-08-01 | Mycogen Corporation | Cloning and expression of Bacillus thuringiensis toxin gene toxic to beetles of the order Coleoptera |
| US5268463A (en) | 1986-11-11 | 1993-12-07 | Jefferson Richard A | Plant promoter α-glucuronidase gene construct |
| US5608142A (en) | 1986-12-03 | 1997-03-04 | Agracetus, Inc. | Insecticidal cotton plants |
| US4837028A (en) | 1986-12-24 | 1989-06-06 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| US5039523A (en) | 1988-10-27 | 1991-08-13 | Mycogen Corporation | Novel Bacillus thuringiensis isolate denoted B.t. PS81F, active against lepidopteran pests, and a gene encoding a lepidopteran-active toxin |
| US5364780A (en) | 1989-03-17 | 1994-11-15 | E. I. Du Pont De Nemours And Company | External regulation of gene expression by inducible promoters |
| ATE225853T1 (de) | 1990-04-12 | 2002-10-15 | Syngenta Participations Ag | Gewebe-spezifische promotoren |
| US5264618A (en) | 1990-04-19 | 1993-11-23 | Vical, Inc. | Cationic lipids for intracellular delivery of biologically active molecules |
| WO1991017424A1 (en) | 1990-05-03 | 1991-11-14 | Vical, Inc. | Intracellular delivery of biologically active substances by means of self-assembling lipid complexes |
| US5498830A (en) | 1990-06-18 | 1996-03-12 | Monsanto Company | Decreased oil content in plant seeds |
| CA2051562C (en) | 1990-10-12 | 2003-12-02 | Jewel M. Payne | Bacillus thuringiensis isolates active against dipteran pests |
| US5173414A (en) | 1990-10-30 | 1992-12-22 | Applied Immune Sciences, Inc. | Production of recombinant adeno-associated virus vectors |
| US5399680A (en) | 1991-05-22 | 1995-03-21 | The Salk Institute For Biological Studies | Rice chitinase promoter |
| US5604121A (en) | 1991-08-27 | 1997-02-18 | Agricultural Genetics Company Limited | Proteins with insecticidal properties against homopteran insects and their use in plant protection |
| TW261517B (enExample) | 1991-11-29 | 1995-11-01 | Mitsubishi Shozi Kk | |
| US5587308A (en) | 1992-06-02 | 1996-12-24 | The United States Of America As Represented By The Department Of Health & Human Services | Modified adeno-associated virus vector capable of expression from a novel promoter |
| US5789156A (en) | 1993-06-14 | 1998-08-04 | Basf Ag | Tetracycline-regulated transcriptional inhibitors |
| US5814618A (en) | 1993-06-14 | 1998-09-29 | Basf Aktiengesellschaft | Methods for regulating gene expression |
| US5837458A (en) | 1994-02-17 | 1998-11-17 | Maxygen, Inc. | Methods and compositions for cellular and metabolic engineering |
| US5605793A (en) | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
| US5608144A (en) | 1994-08-12 | 1997-03-04 | Dna Plant Technology Corp. | Plant group 2 promoters and uses thereof |
| US5659026A (en) | 1995-03-24 | 1997-08-19 | Pioneer Hi-Bred International | ALS3 promoter |
| US6072050A (en) | 1996-06-11 | 2000-06-06 | Pioneer Hi-Bred International, Inc. | Synthetic promoters |
| US6177611B1 (en) | 1998-02-26 | 2001-01-23 | Pioneer Hi-Bred International, Inc. | Maize promoters |
| US6534261B1 (en) | 1999-01-12 | 2003-03-18 | Sangamo Biosciences, Inc. | Regulation of endogenous gene expression in cells using zinc finger proteins |
| CA2371442A1 (en) | 1999-05-04 | 2000-11-09 | Monsanto Technology Llc | Coleopteran-toxic polypeptide compositions and insect-resistant transgenic plants |
| WO2001019859A2 (en) | 1999-09-15 | 2001-03-22 | Monsanto Technology Llc | LEPIDOPTERAN-ACTIVE BACILLUS THURINGIENSIS δ-ENDOTOXIN COMPOSITIONS AND METHODS OF USE |
| PT2359869T (pt) | 2001-12-17 | 2019-04-16 | Univ Pennsylvania | Sequências do vírus adeno-associado (aav) do serotipo 8, vetores contendo as mesmas, e utilizações destas |
| US20050183161A1 (en) | 2003-10-14 | 2005-08-18 | Athenix Corporation | AXMI-010, a delta-endotoxin gene and methods for its use |
| US7629504B2 (en) | 2003-12-22 | 2009-12-08 | Pioneer Hi-Bred International, Inc. | Bacillus thuringiensis cry9 nucleic acids |
| EP2032598B1 (en) | 2006-06-14 | 2012-10-17 | Athenix Corporation | Axmi-031, axmi-039, axmi-040 and axmi-049, a family of delta-endotoxin genes and methods for their use |
| DK2334794T3 (en) | 2008-09-15 | 2017-02-20 | Children's Medical Center Corp | MODULATION OF BCL11A FOR TREATMENT OF HEMOGLOBINOPATHIES |
| WO2010132092A2 (en) | 2009-05-12 | 2010-11-18 | The Scripps Research Institute | Cytidine deaminase fusions and related methods |
| RS55550B1 (sr) | 2009-07-02 | 2017-05-31 | Athenix Corp | Axmi-205 pesticidni gen i postupci za njegovu upotrebu |
| US20130011380A1 (en) * | 2009-12-18 | 2013-01-10 | Blau Helen M | Use of Cytidine Deaminase-Related Agents to Promote Demethylation and Cell Reprogramming |
| US8586832B2 (en) | 2009-12-21 | 2013-11-19 | Pioneer Hi Bred International Inc | Bacillus thuringiensis gene with Lepidopteran activity |
| CN103154247A (zh) | 2010-08-19 | 2013-06-12 | 先锋国际良种公司 | 对鳞翅目昆虫具有活性的新苏云金杆菌基因 |
| US9405700B2 (en) | 2010-11-04 | 2016-08-02 | Sonics, Inc. | Methods and apparatus for virtualization in an integrated circuit |
| EP3124605A1 (en) * | 2012-03-15 | 2017-02-01 | New England Biolabs, Inc. | Methods and compositions for discrimination between cytosine and modifications thereof, and for methylome analysis |
| RS59199B1 (sr) | 2012-05-25 | 2019-10-31 | Univ California | Metode i jedinjenja za rnk-upravljanu ciljanu dnk modifikaciju i za rnk- upravljanu modulaciju transkripta |
| ES2613691T3 (es) | 2012-07-11 | 2017-05-25 | Sangamo Biosciences, Inc. | Métodos y composiciones para el tratamiento de enfermedades por almacenamiento lisosomal |
| EP2898075B1 (en) * | 2012-12-12 | 2016-03-09 | The Broad Institute, Inc. | Engineering and optimization of improved systems, methods and enzyme compositions for sequence manipulation |
| US11053481B2 (en) | 2013-12-12 | 2021-07-06 | President And Fellows Of Harvard College | Fusions of Cas9 domains and nucleic acid-editing domains |
| EP3186375A4 (en) | 2014-08-28 | 2019-03-13 | North Carolina State University | Novel CAS9 PROTEINS AND CHARACTERISTICS FOR DNA TARGETING AND GENOME EDITING |
| AU2015101792A4 (en) * | 2014-12-24 | 2016-01-28 | Massachusetts Institute Of Technology | Engineering of systems, methods and optimized enzyme and guide scaffolds for sequence manipulation |
| US9790490B2 (en) | 2015-06-18 | 2017-10-17 | The Broad Institute Inc. | CRISPR enzymes and systems |
| US11692182B2 (en) * | 2015-10-09 | 2023-07-04 | Monsanto Technology Llc | RNA-guided DNA nucleases and uses thereof |
| US12043852B2 (en) * | 2015-10-23 | 2024-07-23 | President And Fellows Of Harvard College | Evolved Cas9 proteins for gene editing |
| CA3010628A1 (en) * | 2016-03-11 | 2017-09-14 | Pioneer Hi-Bred International, Inc. | Novel cas9 systems and methods of use |
| GB2568182A (en) | 2016-08-03 | 2019-05-08 | Harvard College | Adenosine nucleobase editors and uses thereof |
| GB2573062A (en) * | 2016-10-14 | 2019-10-23 | Harvard College | AAV delivery of nucleobase editors |
| KR102151065B1 (ko) * | 2016-12-23 | 2020-09-02 | 기초과학연구원 | 동물 배아의 염기 교정용 조성물 및 염기 교정 방법 |
| EP3572525A4 (en) * | 2017-01-17 | 2020-09-30 | Institute for Basic Science | PROCEDURE FOR IDENTIFYING AN OFF-TARGET BASIC EDITING SITE BY BREAKING A SINGLE DNA STRAND |
| WO2018172556A1 (en) * | 2017-03-24 | 2018-09-27 | Curevac Ag | Nucleic acids encoding crispr-associated proteins and uses thereof |
| US12297436B2 (en) * | 2017-05-18 | 2025-05-13 | The Broad Institute, Inc. | Systems, methods, and compositions for targeted nucleic acid editing |
| AR114014A1 (es) * | 2017-12-22 | 2020-07-08 | Inst Genetics & Developmental Biology Cas | Sistema de edición de bases y método basado en proteína cpf1 |
| CN109337904B (zh) * | 2018-11-02 | 2020-12-25 | 中国科学院动物研究所 | 基于C2c1核酸酶的基因组编辑系统和方法 |
| CN118813654A (zh) * | 2019-08-12 | 2024-10-22 | 生命编辑制药股份有限公司 | Rna指导的核酸酶及其活性片段及变体以及使用方法 |
-
2019
- 2019-12-20 MX MX2021007835A patent/MX2021007835A/es unknown
- 2019-12-20 AU AU2019416108A patent/AU2019416108B2/en active Active
- 2019-12-20 WO PCT/US2019/068079 patent/WO2020139783A2/en not_active Ceased
- 2019-12-20 CN CN201980091657.4A patent/CN113631704A/zh active Pending
- 2019-12-20 KR KR1020217023648A patent/KR20210149686A/ko active Pending
- 2019-12-20 US US17/418,498 patent/US20220145296A1/en active Pending
- 2019-12-20 NZ NZ778392A patent/NZ778392A/en unknown
- 2019-12-20 ES ES19839624T patent/ES2970169T3/es active Active
- 2019-12-20 SG SG11202106977PA patent/SG11202106977PA/en unknown
- 2019-12-20 JP JP2021538143A patent/JP7572360B2/ja active Active
- 2019-12-20 IL IL312708A patent/IL312708A/en unknown
- 2019-12-20 EP EP23199688.5A patent/EP4339286A3/en active Pending
- 2019-12-20 EP EP19839624.4A patent/EP3902911B1/en active Active
- 2019-12-20 BR BR112021012665A patent/BR112021012665A2/pt unknown
- 2019-12-24 TW TW108147446A patent/TW202039847A/zh unknown
-
2021
- 2021-06-27 IL IL284400A patent/IL284400A/en unknown
- 2021-07-26 ZA ZA2021/05281A patent/ZA202105281B/en unknown
-
2023
- 2023-05-12 US US18/316,698 patent/US12188018B2/en active Active
-
2024
- 2024-01-24 JP JP2024008844A patent/JP2024050676A/ja active Pending
- 2024-07-12 JP JP2024112452A patent/JP2024137967A/ja active Pending
- 2024-09-06 US US18/826,746 patent/US20250066783A1/en active Pending
- 2024-11-26 US US18/960,883 patent/US20250092398A1/en active Pending
-
2025
- 2025-10-06 AU AU2025242270A patent/AU2025242270A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024137967A5 (enExample) | ||
| JPWO2020139783A5 (enExample) | ||
| CN111065647B (zh) | 用于提高碱基编辑精度的融合蛋白 | |
| JP2024083479A5 (enExample) | ||
| JP2024054136A5 (enExample) | ||
| CN112585264B (zh) | 重组型kod聚合酶 | |
| NZ202908A (en) | Physiologically active peptides | |
| JPWO2022056254A5 (enExample) | ||
| CN109679932A (zh) | 一种dna聚合酶、重组载体及它们的制备方法和应用 | |
| JP2002502246A (ja) | 抗微生物ペプチドを大量生産するための方法 | |
| CN110892067A (zh) | 热稳定性提高的phi29DNA聚合酶突变体 | |
| JPWO2021217002A5 (enExample) | ||
| Wakasugi et al. | Structures of tobacco chloroplast genes for tRNAIle (CAU), tRNALeu (CAA), tRNACys (GCA), tRNASer (UGA) and tRNAThr (GGU): a compilation of tRNA genes from tobacco chloroplasts | |
| JPWO2022098993A5 (enExample) | ||
| US20250154490A1 (en) | Mutant cytidine deaminases with improved editing precision | |
| CN115992103B (zh) | 酶突变体及类蛇毒三肽的制备方法 | |
| JPWO2020181102A5 (enExample) | ||
| JPH0420598B2 (enExample) | ||
| US20150037866A1 (en) | Composition, Method and Kit for Obtaining Purified Recombinant Proteins | |
| JPWO2020241876A5 (enExample) | ||
| CN118086340A (zh) | 微型碱基编辑器及其构建方法与应用 | |
| CN114686467B (zh) | 基于蛋白反式剪接的纳米固定化方法、应用及固定化酶 | |
| EP4592394A1 (en) | Base editing of plant cell organelle dna | |
| CN118460654A (zh) | 一种Givosiran的制备方法 | |
| JPWO2021178432A5 (enExample) |